(…) UNODC: Thank you, Mr. Chair, distinguished delegates, ladies and gentlemen. It is my pleasure to brief the Commission on some of the significant efforts UNODC has undertaken over the last year to confront the global drug problem, in line with the Ministerial Declaration of 2019. Given time constraints, I will highlight just a few …
United States of America
Item 5. Implementation of the international drug control treaties (Tuesday morning)
Chair: We will consider scheduling recommendations by WHO and INCB. CND Secretariat: Recalls the substances and scheduling recommendations. Chair: Explains process to schedule substances under 1961, 1971 and 1988 conventions. Butonitazene WHO: Butonitazene, or butoxynitazene, is a benzimidazole-derived synthetic opioid not currently under international control and lacking recognized therapeutic use. It appears as a crystalline …
Item 3. High-level segment (Friday morning)
Canada: Esteemed Chair, Ministers, Heads of Delegation, Distinguished Delegates, and Civil Society Representatives: Canada is experiencing one of the most serious public health crises in our country’s history: an unrelenting toxic drug and overdose crisis. The impact and scope of the toxic drug crisis is devastating and more complex than ever. Tragically, we have seen …
Round Table 2 – The Way Forward: The Road to 2029
Germany/Chair: Hello, welcome to our discussion regarding the way forward in advancing the implementation of all international drug policy commitments in light of the 2029 finally view of certain 2019 Ministerial Declaration in accordance with CND Resolution 66 Adopted by the Commission last March, this roundtable will consist of panel interventions followed by an interactive …
Plenary Item 6: Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem
Plenary Item 6 Follow-up to the implementation at the national, regional and international levels of all commitments, as reflected in the Ministerial Declaration of 2019, to address and counter the world drug problem Chair: I give the floor to the Youth Forum. Youth Forum: We are 34 youth from 28 countries. We realise substance use …
Side Event: Addressing the Global Synthetic Drug Problem: UNODC Synthetic Drug Strategy
Organizer: UNODC Laboratory and Scientific Service Co-sponsors: Canada & United States of America Co-sponsors: Canada & United States of America Moderator: Mr. Jean-Luc Lemahieu, Director, Division of Policy Analysis and Public Affairs, UNODC Summary: The global synthetic drug problem is complex requiring dynamic and comprehensive strategies supported by interagency and international cooperation. Join us to learn …